Amgen Europe B.V.
Manufacturer / marketing-authorisation holder
Amgen Europe B.V. — 113 products across 2 markets, 33 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Amgen Europe B.V. — 113 productos en 2 mercados, 33 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Amgen Europe B.V. —— 共 113 个产品,覆盖 2 个市场、33 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
113 products · 2 markets · 33 brand names
113 productos · 2 mercados · 33 marcas
113 个产品 · 2 个市场 · 33 个品牌名
Products by country
ES
Source: cima.aemps.es
EU
Source: www.ema.europa.eu
| Brand | Active ingredient(s) | Form |
|---|---|---|
| AMGEVITA | Adalimumab | unknown |
| ARANESP | Darbepoetin Alfa | unknown |
| BLINCYTO | Blinatumomab | unknown |
| IMDYLLTRA | Tarlatamab | unknown |
| Imlygic | Talimogene Laherparepvec | unknown |
| KYPROLIS | 卡非佐米 | unknown |
| Kanjinti | 曲妥珠单抗 | unknown |
| Lumykras 120mg tablets | Sotorasib | unknown |
| MVASI | 贝伐珠单抗 | unknown |
| Mimpara 30mg tablets | 盐酸西那卡塞 | unknown |
| Neulasta | Pegfilgrastim | unknown |
| Nplate | Romiplostim | unknown |
| Otezla | 阿普米司特 | unknown |
| PARSABIV | Etelcalcetide | unknown |
| Prolia | Denosumab | unknown |
| REPATHA | Evolocumab | unknown |
| RISTEMPA | Pegfilgrastim | unknown |
| SOLYMBIC | Adalimumab | unknown |
| TEPEZZA | Teprotumumab | unknown |
| UPLIZNA | Inebilizumab | unknown |
| Vectibix | Panitumumab | unknown |
| XGEVA | Denosumab | unknown |
Showing the first 52 of 113 products (ordered by country).
Mostrando los primeros 52 de 113 productos (orden por país).
仅显示前 52 / 113 个产品(按国家排序)。